At the Université de Sherbrooke, the status of an institute aims to give added value to research activities in a particular field. At the Pharmacology Institute of Sherbrooke (IPS), the main objective is the development of drugs and diagnostic tools.
The expertise of IPS researchers covers a broad spectrum that includes pharmacology, medicinal and organic chemistry, physiology, medicine, biomedical imaging, biophysics, electrical and biotechnological engineering, structural biology and bioinformatics. Their many achievements and discoveries cover the spectrum ranging from the generation of knowledge on fundamental biological or chemical mechanisms, the creation of molecules of therapeutic interest or molecular imaging agents for various diseases, Technologies for medical imaging, cell biology or bioinformatics.
The IPS promotes the emergence of interdisciplinary collaborations in the context of drug development, diagnostic agents, validation of therapeutic and / or diagnostic targets, and technologies to improve these processes. He also assists researchers in creating value and develops their links with the private sector, supporting the development of a translational research that will allow the advancement of fundamental discoveries towards products that will benefit the patients.